[Dual platelet inhibition with clopidogrel and ASS. Who profits from the combination?].
D000208:Acute Disease; D000789:Angina, Unstable / Q000188:drug therapy*; D001241:Aspirin / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D000077144:Clopidogrel; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006801:Humans; D002546:Ischemic Attack, Transient / Q000188:drug therapy*; D009203:Myocardial Infarction / Q000188:drug therapy*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D012307:Risk Factors; D015607:Stents / Q000009:adverse effects; D020521:Stroke / Q000188:drug therapy*; D013577:Syndrome; D013927:Thrombosis / Q000517:prevention & control; D013988:Ticlopidine / Q000008:administration & dosage* / Q000031:analogs & derivatives*
D016861:Cyclooxygenase Inhibitors; D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin